Merck & Co. (MRK)
(Delayed Data from NYSE)
$115.20 USD
+1.38 (1.21%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $115.00 -0.20 (-0.17%) 7:22 PM ET
3-Hold of 5 3
C Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
MRK 115.20 +1.38(1.21%)
Will MRK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRK
Moderna (MRNA) Q2 Earnings Beat, Stock Down on Guidance Slash
Merck (MRK) Q2 Earnings & Sales Beat Estimates, Cuts '24 EPS View
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Case-Shiller Home Prices Tick in Higher
Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
Pre-Markets Flat Again Ahead of Fed Report Tomorrow
Other News for MRK
Merck call volume above normal and directionally bullish
Argus Research Remains a Buy on Merck & Company (MRK)
Interesting MRK Put And Call Options For March 2025
UK shareholder meetings calendar - next 7 days
UK dividends calendar